main
proteinas
sever
acut
respiratori
syndrom
sar
coronaviru
sarscov
pro
wide
consid
major
drug
target
develop
antisar
treatment
base
chemic
structur
lead
compound
previou
screen
design
synthes
number
nonpeptidyl
inhibitor
shown
significantli
improv
inhibitori
activ
sarscov
pro
ic
valu
nm
absenc
sarscov
pro
crystal
structur
complex
synthet
inhibitor
molecular
dock
tool
employ
studi
possibl
interact
inhibitor
sarscov
pro
dock
result
suggest
two
major
mode
initi
bind
inhibitor
activ
site
sarscov
pro
also
establish
structur
basi
core
design
inhibitor
show
function
common
present
inhibitor
tend
cluster
specif
pocket
addit
intrins
flexibl
pocket
allow
accommod
bulki
group
benzen
ring
suggest
structur
plastic
exploit
optim
inhibitorenzym
interact
promot
tighter
bind
mode
importantli
result
provid
structur
basi
ration
design
widespectrum
antivir
drug
target
chymotrypsinlik
cystein
proteinas
coronavirus
picornavirus
winter
form
atyp
pneumonia
later
term
sever
acut
respiratori
syndrom
sar
broke
southern
china
rapidli
spread
countri
region
five
contin
approxim
peopl
infect
death
report
ensu
month
caus
agent
sar
novel
human
coronaviru
sarscov
similar
coronavirus
rna
genom
sarscov
encod
least
two
viral
proteinas
one
main
proteinas
pro
pro
highli
conserv
proteinas
among
coronavirus
respons
major
proteolyt
process
two
larg
viral
polyprotein
replicas
cleavag
product
replicas
requir
assembl
membran
complex
infect
cell
viral
rna
genom
replic
interrupt
either
viral
rna
translat
polyprotein
proteolyt
process
abolish
viral
rna
replic
indispens
involv
polyprotein
process
sarscov
pro
upstream
mani
replic
event
viral
life
cycl
reduc
block
peptidas
function
pro
could
profound
impact
lower
progeni
viru
yield
enhanc
cell
surviv
therefor
sarscov
pro
attract
target
develop
antisar
drug
function
quaternari
assembl
sarscov
pro
believ
dimer
two
protom
orient
almost
perpendicular
one
anoth
protom
consist
three
domain
residu
ii
residu
iii
residu
domain
ii
made
bbarrel
motif
similar
domain
chymotrypsintyp
serin
proteas
proteinas
picornavirus
substrat
bind
site
nearbi
catalyt
dyad
consist
residu
locat
cleft
domain
ii
domain
iii
contain
five
ahelic
connect
domain
ii
via
extend
loop
residu
play
essenti
role
proteolyt
activ
sarscov
pro
maintain
proper
conform
dimer
substrat
bind
site
sarscov
pro
probe
use
sever
class
inhibitor
chloromethyl
keton
epoxid
michael
acceptor
among
function
group
known
form
coval
bond
nucleophil
sulfur
atom
therebi
lead
inactiv
sarscov
pro
enzymat
activ
similar
main
proteinas
transmiss
gastroenter
viru
tgev
human
coronaviru
strain
sarscov
pro
exhibit
welldefin
pocket
seem
highli
structur
conserv
among
coronavirus
vitro
vivo
studi
show
residu
posit
substrat
involv
substrat
bind
recognit
cleavag
consequ
pocket
sarscov
pro
princip
target
site
antisar
widespectrum
anticoronaviru
drug
variou
experiment
techniqu
model
method
structurebas
discoveri
experiment
screen
virtual
screen
employ
search
effect
antisar
inhibitor
although
efficaci
compound
verifi
character
biochem
andor
cell
culturebas
assay
inhibit
mechan
remain
unclear
primarili
due
lack
structur
inform
recent
largescal
highthroughput
screen
antisar
compound
identifi
ethanon
potent
inhibitor
sarscov
pro
ic
valu
lm
order
deriv
even
better
antisarscov
pro
compound
synthes
number
nonpeptid
compound
base
chemic
structur
compound
show
signific
improv
inhibitori
activ
paper
report
vitro
inhibit
sarscov
pro
seri
nonpeptid
compound
design
basi
tabl
analyz
possibl
mode
interact
new
class
nonpeptidyl
inhibitor
sarscov
pro
use
molecular
dock
tool
dock
result
also
allow
us
put
forward
construct
suggest
futur
design
antisar
pro
inhibitor
prior
virtual
dock
compound
sort
two
group
base
chemic
characterist
group
contain
ester
function
chloropyridin
moieti
inherit
parent
compound
addit
group
compound
furan
ring
connect
derivat
benzen
moieti
tabl
wherea
group
ii
compound
derivat
sixmemb
cyclic
aromat
system
link
central
ester
function
tabl
gener
group
compound
better
inhibitor
sarscov
pro
group
ii
compound
shown
lower
ic
valu
tabl
interestingli
posit
electronwithdraw
substitu
termin
aromat
ring
seem
influenc
inhibitori
efficaci
compound
dramat
exampl
differ
posit
nitrogen
atom
pyridin
moieti
rel
carbonyl
function
compound
associ
fourfold
dispar
ic
valu
best
group
inhibitor
compound
contain
either
chlorid
nitro
group
para
posit
rel
furan
function
move
nitro
group
compound
either
ortho
compound
meta
compound
posit
led
threefold
eightfold
increas
ic
valu
respect
similar
manner
compound
compound
group
ii
bear
chloroor
nitrosubstitu
benzen
ring
directli
connect
central
ester
function
para
ortho
meta
posit
rel
ester
bond
respect
posit
substitu
latter
three
compound
much
less
impact
inhibitori
activ
sarscov
pro
although
metasubstitut
compound
markedli
weaker
inhibitor
either
compound
compound
termin
conjug
ring
show
inhibitori
activ
roughli
equival
best
group
compound
two
possibl
bind
mode
compound
similar
chemic
structur
except
differ
substitu
benzen
ring
clearli
identifi
first
bind
mode
mode
group
compound
occupi
primarili
volum
extend
substrat
bind
site
fig
figur
show
predict
interact
enzym
compound
activ
site
exampl
chloropyridin
moieti
inhibitor
bind
insid
pocket
orient
wherein
pyridin
plane
parallel
two
wall
site
form
residu
residu
respect
dock
complex
compound
common
nitrogen
atom
chloropyridin
moieti
receiv
hydrogen
bond
n
specificitydetermin
residu
fig
similarli
furan
moieti
group
inhibitor
occupi
volum
pocket
form
van
der
waal
interact
shown
contrast
benzen
ring
group
inhibitor
mode
show
rel
larger
conform
variat
compound
contain
parasubstitut
benzen
ring
fit
pocket
well
compound
contain
orthoor
metaori
group
benzen
ring
caus
benzen
moieti
compound
push
outward
site
avoid
steric
hindranc
benzyl
substitu
side
chain
dock
model
suggest
hydrophob
interact
form
residu
benzen
ring
moieti
wherea
main
chain
nh
form
hydrogen
bond
orthoori
nitro
substitu
benzen
ring
bind
mode
ester
function
inhibitor
approxim
c
catalyt
residu
tabl
column
carbonyl
oxygen
atom
inhibitor
point
oxyanion
hole
sarscov
pro
compound
receiv
hydrogen
bond
main
chain
nh
ester
known
substrat
chymotrypsintyp
serin
proteas
enzym
structur
similar
catalyt
domain
sarscov
pro
suggest
ester
bond
group
inhibitor
bound
conform
could
attack
nucleophil
sulfur
lead
format
acyl
enzym
second
bind
mode
group
compound
extend
specif
pocket
mode
fig
similar
fashion
bind
mode
chloropyridin
moieti
group
inhibitor
also
locat
pocket
howev
orient
chloropyridin
ring
roughli
perpendicular
chloropyridin
ring
bind
mode
plane
ring
parallel
tabl
structur
inhibitori
activ
set
nonpeptidyl
compound
group
base
chemic
structur
bind
free
energi
predict
bind
mode
b
bind
free
energi
predict
bind
mode
c
distanc
carbonyl
carbon
compound
sulfur
atom
pdb
bind
mode
distanc
carbonyl
carbon
compound
sulfur
atom
pdb
bind
mode
e
distanc
carbonyl
carbon
compound
sulfur
atom
pdb
bind
mode
f
distanc
carbonyl
carbon
compound
sulfur
atom
pdb
bind
mode
bind
free
energi
predict
bind
mode
b
distanc
carbonyl
carbon
acycl
ester
bond
sulfur
atom
pdb
bind
mode
c
distanc
carbonyl
carbon
acycl
ester
bond
sulfur
atom
pdb
bind
mode
floor
site
form
side
chain
mchlorin
pyridin
ring
point
solvent
channel
back
side
pocket
occupi
volum
close
chlorid
ion
observ
crystal
structur
unligand
sarscov
pdb
code
dock
complex
contain
compound
chlorin
hydrogen
bond
c
fig
residu
form
hydrophob
interact
pyridin
ring
inhibitor
furan
ring
bind
mode
situat
top
make
van
der
waal
interact
residu
pocket
larg
enough
accommod
benzen
ring
group
inhibitor
despit
presenc
variou
substitu
differ
posit
ring
residu
contribut
mostli
hydrophob
interact
benzen
ring
main
chain
nh
form
two
hydrogen
bond
oxygen
atom
furan
carbonyl
oxygen
bposit
central
ester
bond
group
compound
addit
nitro
function
compound
form
hydrogen
bond
n
fig
bind
mode
distanc
carbonyl
carbon
ester
function
inhibitor
c
rang
tabl
column
inhibitor
bound
mode
unlik
attack
sulfur
nucleophil
due
long
distanc
constraint
therefor
bind
mode
like
repres
mechan
competit
inhibit
inhibitor
block
activ
sarscov
pro
deni
entri
substrat
activ
site
significantli
bind
hypothesi
suggest
way
improv
design
potent
noncoval
sarscov
pro
inhibitor
promot
tighter
bind
discuss
later
section
extend
endtoend
length
group
ii
compound
shorter
group
compound
consequ
span
one
substrat
bind
site
commonli
observ
bind
mode
orient
extend
catalyt
dyad
pocket
mode
bind
mode
group
compound
mchloropyridin
ring
group
ii
inhibitor
reliabl
dock
insid
site
mchlorin
atom
point
solvent
fig
derivat
benzen
function
group
ii
compound
dock
near
catalyt
residu
mode
view
partial
bind
mode
akin
fragment
bind
aromat
system
carbonyl
side
ester
bond
form
mostli
van
der
waal
contact
residu
howev
orient
regard
rest
compound
vari
substanti
fig
hydrogen
bond
form
group
ii
compound
sarscov
pro
also
show
polar
pattern
nitrogen
atom
pyridin
ring
compound
hydrogen
bond
n
also
receiv
hydrogen
bond
bcarbonyl
oxygen
atom
group
ii
compound
furthermor
compound
main
chain
n
form
bifurc
hydrogen
bond
carbonyl
oxygen
ester
bond
carbonyl
oxygen
coumarin
moieti
respect
fig
bind
mode
group
ii
inhibitor
averag
distanc
carbonyl
carbon
atom
central
ester
bond
sulfur
atom
compar
inhibitor
group
bind
mode
ester
bond
group
ii
inhibitor
place
much
closer
catalyt
dyad
carbonyl
oxygen
atom
central
ester
point
oxyanion
hole
therefor
group
ii
compound
bound
mode
potenti
expos
higher
risk
enzymat
hydrolysi
estim
free
energi
bind
dg
enzym
inhibitor
predict
autodock
base
new
score
function
develop
use
amber
forc
field
set
coeffici
although
autodock
provid
absolut
bind
free
energi
predict
dg
use
approxim
rank
inhibitor
accord
predict
bind
affin
group
compound
signific
differ
bind
free
energi
mode
dg
bind
mode
dg
tabl
suggest
group
compound
compar
tendenc
adopt
either
conform
prior
possibl
coval
modif
sarscov
pro
enzym
bind
free
energi
group
ii
compound
significantli
higher
group
compound
except
compound
agreement
gener
trend
sarscov
pro
strongli
inhibit
group
group
ii
compound
compound
show
bind
free
energi
closer
exhibit
group
compound
probabl
larger
aromat
stabil
effect
naphthalen
moieti
compound
coumarin
moieti
compound
make
central
ester
bond
less
suscept
nucleophil
attack
c
correspondingli
two
compound
exhibit
better
antisarscov
pro
activ
group
ii
inhibitor
inhibitor
use
studi
bind
activ
site
sarscov
pro
primarili
hydrophob
contact
dock
result
clearli
show
moieti
esterbas
nonpeptidyl
inhibitor
strong
propens
enter
specif
pocket
sarscov
pro
accordingli
residu
form
pocket
play
major
part
interact
inhibitor
sarscov
pro
signific
chloropyridin
function
resembl
cognat
residu
term
chemic
properti
consequ
interact
sarscov
pro
chloropyridin
moieti
like
differ
sarscov
pro
derivat
chloropyridin
group
yield
margin
improv
efficaci
result
inhibitor
indic
design
may
maxim
potenti
concern
pocket
sarscov
pro
sinc
pocket
coronavir
pro
structur
conserv
similar
picornavir
pro
inhibitor
describ
studi
least
basic
design
prove
use
develop
widespectrum
antivir
compound
earli
indic
came
observ
parent
compound
show
good
inhibitori
activ
sarscov
pro
hav
pro
correspond
ic
valu
high
nanomolar
rang
second
hotspot
could
target
antisarscov
pro
compound
residu
play
dual
role
activ
c
catalyt
cycl
gener
base
well
form
part
specif
pocket
bind
mode
togeth
form
half
total
hydrophob
interact
group
inhibitor
tabl
form
wall
pocket
opposit
residu
also
major
contributor
hydrophob
interact
bind
mode
tabl
distanc
c
carbonyl
carbon
atom
ester
function
group
ii
inhibi
total
tor
significantli
shorter
nucleophil
sulfur
correspond
atom
group
inhibitor
bind
mode
tabl
column
tabl
column
worth
mention
model
structur
use
dock
sarscov
pro
coval
modifi
c
posit
nucleophil
sulfur
atom
rel
activ
site
residu
shift
significantli
c
unligand
enzym
structur
pdb
code
eg
fig
recent
xray
crystallograph
analys
sarscov
pro
complex
peptidyl
inhibitor
indic
format
tetrahedr
intermedi
substrat
hydrolysi
take
place
without
requir
previous
observ
conform
chang
consequ
align
structur
onto
dock
molecul
obtain
altern
coordin
nucleophil
sulfur
repres
posit
c
rest
state
substrateinhibitor
first
approach
distanc
involv
c
recalcul
clear
carbonyl
carbon
atom
group
ii
compound
closer
c
group
compound
tabl
column
note
calcul
distanc
group
ii
compound
compound
bind
mode
shorter
sum
van
der
waal
radii
carbonyl
oxygen
thiol
sulfur
atom
suggest
strong
propens
coval
attach
inhibitor
c
summari
dock
studi
provid
reason
structur
interpret
vitro
activ
new
class
nonpeptidyl
antisarscov
pro
inhibitor
suggest
chloropyridin
function
context
ester
compound
specif
bind
substrat
bind
site
sarscov
pro
interact
site
sarscov
pro
chloropyridin
function
like
play
import
role
initi
bind
inhibitor
enzym
vitro
wherea
rate
subsequ
watermedi
hydrolysi
result
acyl
enzym
depend
chemic
properti
leav
group
carbonyl
side
ester
bond
worth
mention
addit
dock
studi
indic
chloropyridin
function
compound
like
target
site
hav
pro
well
data
shown
correl
well
high
structur
similar
activ
site
sarscov
pro
hav
pro
total
inform
obtain
structur
analys
may
incorpor
futur
design
potent
antisarscov
pro
inhibitor
due
hydrolyz
ester
bond
compound
inhibitori
effect
sarscov
pro
like
involv
coval
attach
inhibitor
nucleophil
cystein
modif
individu
combin
basi
compound
may
improv
efficaci
inhibit
sarscov
pro
andor
structur
similar
viral
proteinas
ester
bond
could
replac
function
group
react
enhanc
inhibitori
effect
inhibitor
prone
take
conform
possibl
candid
reactiv
function
epoxid
michael
acceptor
azid
side
chain
improv
aim
increas
interact
site
inhibitor
would
creat
mode
inhibit
virtual
deni
entri
peptidyl
substrat
bifurc
modif
diverg
furan
ring
could
principl
involv
site
bind
inhibitor
enzym
therebi
maxim
interact
chemic
synthes
vitro
character
compound
describ
studi
done
essenti
report
previous
summari
pyridinyl
ester
prepar
parallel
synthesi
coupl
reaction
commerci
avail
carboxyl
acid
use
method
b
briefli
method
edci
mmol
equiv
hobt
mmol
equiv
dipea
mmol
equiv
mmol
equiv
ad
solut
carboxyl
acid
mmol
equiv
dmf
ml
rt
h
stir
solvent
remov
vacuo
afford
crude
mixtur
method
b
solut
carboxyl
acid
mmol
equiv
dcm
ml
rt
ad
thionyl
chlorid
mmol
equiv
dropwis
catalyt
amount
dmf
drop
overnight
stir
solvent
remov
vacuo
afford
acyl
chlorid
product
solut
acyl
chlorid
dcm
ml
ad
dropwis
solut
mmol
equiv
pyridin
ml
equiv
dcm
ml
h
stir
rt
solvent
remov
vacuo
afford
crude
mixtur
crude
mixtur
obtain
method
b
purifi
hplcm
autom
instrument
choos
ration
conform
sarscov
pro
enzym
dock
experi
sever
crystal
structur
sarscov
pro
deposit
protein
data
bank
pdb
first
align
leastsquar
fit
algorithm
sybyl
packag
tripo
inc
st
loui
usa
conform
pocket
clearli
show
structur
variat
among
structur
fig
clariti
two
model
overlaid
depth
pocket
could
affect
dock
result
dramat
simpli
larger
inhibitor
dock
smaller
pocket
crystal
structur
sarscov
pro
complex
azapeptid
epoxid
ape
pdb
code
chain
chosen
construct
predict
model
seri
inhibitor
benzen
ring
posit
ape
accommod
cozili
pocket
result
rel
larger
size
pocket
avail
crystal
structur
sarscov
pro
fig
b
therefor
use
structur
enzym
principl
allow
inhibitor
adopt
conform
would
maxim
interact
inhibitor
site
enzym
coordin
inhibitor
ape
solvent
molecul
first
remov
correspond
pdb
file
essenti
hydrogen
atom
kollman
unit
atom
charg
ad
protein
structur
use
molecular
model
softwar
sybyl
version
tripo
inc
st
loui
usa
fragment
volum
atom
solvat
paramet
import
comput
bind
free
energi
assign
use
addsol
modul
autodock
program
structur
studi
compound
construct
use
sybyl
tripo
inc
st
loui
usa
hydrogen
atom
ad
inhibitor
structur
partial
atom
charg
calcul
use
gasteigermarsili
method
geometri
optim
perform
appli
tripo
forc
field
sybyl
tripo
inc
st
loui
usa
possibl
rotat
bond
compound
assign
use
program
autotor
autodock
allow
search
flexibl
conform
compound
dock
process
dock
program
autodock
use
perform
autom
molecular
dock
lamarckian
genet
algorithm
lga
appli
deal
inhibitorenzym
interact
grid
map
point
space
equal
gener
use
autogrid
program
evalu
bind
energi
compound
protein
dock
paramet
set
default
valu
except
step
size
translat
orient
torsion
angl
number
gener
energi
evalu
dock
inhibitorenzym
complex
rank
accord
predict
bind
energi
conform
ideal
geometri
dock
structur
